Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

Visualizza tutta la documentazione

G7048

Sigma-Aldrich

Proguanil hydrochloride

≥95% (HPLC)

Sinonimo/i:

Chlorguanide, N1-(4-Chlorophenyl)-N5-isopropylbiguanide

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali

Scegli un formato

10 MG
CHF 80.90
50 MG
CHF 307.00

CHF 80.90

Check Cart for Availability
Richiedi un ordine bulk
Tutte le immagini(1)

Scegli un formato

Cambia visualizzazione
10 MG
CHF 80.90
50 MG
CHF 307.00

About This Item

Formula empirica (notazione di Hill):
C11H16ClN5·HCl
Numero CAS:
637-32-1
Peso molecolare:
290.19
Numero CE:
211-283-7
Numero MDL:
MFCD01732193
Codice UNSPSC:
51101906
ID PubChem:
329799959
NACRES:
NA.77

CHF 80.90

Check Cart for Availability
Richiedi un ordine bulk

Livello qualitativo

100

Saggio

≥95% (HPLC)

Stato

solid

Condizioni di stoccaggio

desiccated

Solubilità

acetonitrile: water: ~1 mg/mL (60/40)

Ideatore

AstraZeneca

Temperatura di conservazione

2-8°C

Stringa SMILE

Cl.CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1

InChI

1S/C11H16ClN5.ClH/c1-7(2)15-10(13)17-11(14)16-9-5-3-8(12)4-6-9;/h3-7H,1-2H3,(H5,13,14,15,16,17);1H
SARMGXPVOFNNNG-UHFFFAOYSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Applicazioni

Proguanil (chlorguanide) may be used in anti-parasitic protozoan drug development to study its pharmacokinetics, metabolism, safety, efficacy and methods of delivery as an antimalarial drug.

Azioni biochim/fisiol

Chlorguanide (proguanil) is combined with atovaquone for malaria prophylaxis. The two compounds act synergistically to inhibit the plasmodial dihydrofolate reductase (DHFR) and interrupt the electron transport chain. Mutations in DHFR account for the development of resistant strains.

Caratteristiche e vantaggi

This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Pittogrammi

Skull and crossbones
GHS06

Avvertenze

Danger

Indicazioni di pericolo

H301

Classi di pericolo

Acute Tox. 3 Oral

Codice della classe di stoccaggio

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
0000053138
0000053137
0000186344
0000186343
050M4719V

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 9

1 of 9

Alexidine dihydrochloride ≥95% (HPLC)

Sigma-Aldrich

A8986

Alexidine dihydrochloride

2’-C-Methylcytidine ≥95% (HPLC), powder

Sigma-Aldrich

M4949

2′-C-Methylcytidine

Chlorhexidine dihydrochloride ≥98%

Sigma-Aldrich

C8527

Chlorhexidine dihydrochloride

Sumatriptan succinate ≥98% (HPLC), solid

Sigma-Aldrich

S1198

Sumatriptan succinate

Atovaquone Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1591

Atovaquone

Chlorhexidine diacetate salt hydrate bis(biguanide) antimicrobial

Sigma-Aldrich

C6143

Chlorhexidine diacetate salt hydrate

Arbidol hydrochloride ≥98% (HPLC)

Sigma-Aldrich

SML0860

Arbidol hydrochloride

Amodiaquin dihydrochloride dihydrate analytical standard

Supelco

A2799

Amodiaquin dihydrochloride dihydrate

Pyrimethamine VETRANAL®, analytical standard

Supelco

46706

Pyrimethamine

S Looareesuwan et al.
The American journal of tropical medicine and hygiene, 60(4), 533-541 (1999-05-29)
The continuing spread of drug-resistant malaria emphasizes the need for new antimalarial drugs. Atovaquone is a broad-spectrum antiprotozoal drug with a novel mechanism of action, via inhibition of parasite mitochondrial electron transport, and a favorable safety profile. Early studies with
Sarah Donegan et al.
Statistics in medicine, 31(29), 3840-3857 (2012-07-13)
Mixed treatment comparison (MTC) meta-analysis allows several treatments to be compared in a single analysis while utilising direct and indirect evidence. Treatment by covariate interactions can be included in MTC models to explore how the covariate modifies the treatment effects.
Olivier Bouchaud et al.
Malaria journal, 11, 212-212 (2012-06-23)
Malaria continues to be amongst the most frequent infectious diseases imported to Europe. Whilst European treatment guidelines are based on data from studies carried out in endemic areas, there is a paucity of original prospective treatment data. The objective was
Patricia Schlagenhauf et al.
Expert review of anti-infective therapy, 10(5), 537-546 (2012-06-19)
The concept of 'standby emergency treatment' (SBET) describes the strategy where travelers carry an emergency malaria treatment for self-administration when no medical attention is available or for use under medical supervision after a confirmed malaria diagnosis, and raises many issues
Laura C Steinhardt et al.
The American journal of tropical medicine and hygiene, 85(6), 1015-1024 (2011-12-07)
Because of recent declining malaria transmission in Latin America, some authorities have recommended against chemoprophylaxis for most travelers to this region. However, the predominant parasite species in Latin America, Plasmodium vivax, can form hypnozoites sequestered in the liver, causing malaria
Visualizza tutti i documenti correlati

Articoli

Bioactive Molecules for Immunology Research

Bioactive small molecules for immune system signaling target identification/validation and antibiotics, antivirals, and antifungals offered.

Questions

Reviews

No rating value

Active Filters

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.